Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of biologically active molecules targeting central nervous system disorders. Its structure incorporates a protected amine and a fluorinated pyrrolidine ring, making it valuable for medicinal chemistry efforts focused on enhancing metabolic stability and binding affinity. Commonly employed in the preparation of enzyme inhibitors and receptor modulators, especially in projects involving fluorine scanning to optimize pharmacokinetic properties. The tert-butyl carbamate group allows for selective deprotection, enabling further functionalization in multi-step synthetic routes.